{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:02:37Z","timestamp":1768780957842,"version":"3.49.0"},"reference-count":25,"publisher":"American Diabetes Association","issue":"1","license":[{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"vor","delay-in-days":76,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/08\/020\/24617"],"award-info":[{"award-number":["PG\/08\/020\/24617"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Diabetes increases mortality in patients with chronic heart failure (CHF) and reduced left ventricular ejection fraction. Studies have questioned the safety of \u03b2-adrenoceptor blockers (\u03b2-blockers) in some patients with diabetes and reduced left ventricular ejection fraction. We examined whether \u03b2-blockers and ACE inhibitors (ACEIs) are associated with differential effects on mortality in CHF patients with and without diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We conducted a prospective cohort study of 1,797 patients with CHF recruited between 2006 and 2014, with mean follow-up of 4 years. \u03b2-Blocker dose was expressed as the equivalent dose of bisoprolol (mg\/day) and ACEI dose as the equivalent dose of ramipril (mg\/day). Cox regression analysis was used to examine the interaction between diabetes and drug dose on all-cause mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Patients with diabetes were prescribed larger doses of \u03b2-blockers and ACEIs than were patients without diabetes. Increasing \u03b2-blocker dose was associated with lower mortality in patients with diabetes (8.9% per mg\/day; 95% CI 5\u201312.6) and without diabetes (3.5% per mg\/day; 95% CI 0.7\u20136.3), although the effect was larger in people with diabetes (interaction P = 0.027). Increasing ACEI dose was associated with lower mortality in patients with diabetes (5.9% per mg\/day; 95% CI 2.5\u20139.2) and without diabetes (5.1% per mg\/day; 95% CI 2.6\u20137.6), with similar effect size in these groups (interaction P = 0.76).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Increasing \u03b2-blocker dose is associated with a greater prognostic advantage in CHF patients with diabetes than in CHF patients without diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc17-1406","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:40:24Z","timestamp":1507250424000},"page":"136-142","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":36,"title":["Mortality Reduction Associated With \u03b2-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes"],"prefix":"10.2337","volume":"41","author":[{"given":"Klaus K.","family":"Witte","sequence":"first","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Drozd","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.N.","family":"Walker","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peysh A.","family":"Patel","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica C.","family":"Kearney","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Chapman","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Sapsford","sequence":"additional","affiliation":[{"name":"Cardiology Department, Leeds Teaching Hospitals NHS Trust, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gierula","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria F.","family":"Paton","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Lowry","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9376-8814","authenticated-orcid":false,"given":"Mark T.","family":"Kearney","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7844-3600","authenticated-orcid":false,"given":"Richard M.","family":"Cubbon","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2017,10,5]]},"reference":[{"key":"2022031301250748900_B1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"2022031301250748900_B2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2022031301250748900_B3","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1161\/CIRCRESAHA.116.306924","article-title":"Heart failure considerations of antihyperglycemic medications for type 2 diabetes","volume":"118","author":"Standl","year":"2016","journal-title":"Circ Res"},{"key":"2022031301250748900_B4","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus \u2013 mechanisms, management and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"2022031301250748900_B5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031301250748900_B6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2337\/dc16-2016","article-title":"Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA Heart Failure Long-Term Registry","volume":"40","author":"Dauriz","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031301250748900_B7","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"2022031301250748900_B8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1479164112471064","article-title":"Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology","volume":"10","author":"Cubbon","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"2022031301250748900_B9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/CIRCHEARTFAILURE.110.959882","article-title":"Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras","volume":"4","author":"Cubbon","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2022031301250748900_B10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N Engl J Med"},{"key":"2022031301250748900_B11","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","author":"MERIT-HF Study Group","year":"1999","journal-title":"Lancet"},{"key":"2022031301250748900_B12","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/CIRCULATIONAHA.104.500546","article-title":"Mechanisms and models in heart failure: the biomechanical model and beyond","volume":"111","author":"Mann","year":"2005","journal-title":"Circulation"},{"key":"2022031301250748900_B13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.117.09259","article-title":"Risk of cardiovascular events in patients with diabetes mellitus on \u03b2-blockers","volume":"70","author":"Tsujimoto","year":"2017","journal-title":"Hypertension"},{"key":"2022031301250748900_B14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.echo.2006.03.032","article-title":"American Society of Echocardiography minimum standards for the cardiac sonographer: a position paper","volume":"19","author":"Bierig","year":"2006","journal-title":"J Am Soc Echocardiogr"},{"key":"2022031301250748900_B15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/dom.12878","article-title":"Effects of \u03b2-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart disease","volume":"19","author":"Tsujimoto","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"2022031301250748900_B16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2016.06.061","article-title":"Prognostic implications of type 2 diabetes mellitus in ischemic and nonischemic heart failure","volume":"68","author":"Johansson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2022031301250748900_B17","doi-asserted-by":"crossref","first-page":"277.e1","DOI":"10.1016\/j.ahj.2007.05.001","article-title":"Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"154","author":"Greenberg","year":"2007","journal-title":"Am Heart J"},{"key":"2022031301250748900_B18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cjca.2012.03.020","article-title":"Sympathetic activation and vasoregulation in response to carbohydrate ingestion in patients with congestive heart failure","volume":"29","author":"Scott","year":"2013","journal-title":"Can J Cardiol"},{"key":"2022031301250748900_B19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1053\/euhj.2000.2407","article-title":"Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure","volume":"22","author":"Brunner-La Rocca","year":"2001","journal-title":"Eur Heart J"},{"key":"2022031301250748900_B20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1479164116653342","article-title":"Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fraction","volume":"13","author":"Walker","year":"2016","journal-title":"Diab Vasc Dis Res"},{"key":"2022031301250748900_B21","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0735-1097(02)02490-7","article-title":"Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure","volume":"40","author":"Kearney","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2022031301250748900_B22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ejheart.2005.11.012","article-title":"Heart rate turbulence and death due to cardiac decompensation in patients with chronic heart failure","volume":"8","author":"Moore","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"2022031301250748900_B23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ahj.2007.03.010","article-title":"Beta-blocker dosing in community-based treatment of heart failure","volume":"153","author":"Fowler","year":"2007","journal-title":"Am Heart J"},{"key":"2022031301250748900_B24","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2017.03.563","article-title":"Achieving a maximally tolerated \u03b2-blocker dose in heart failure patients: is there room\u00a0for\u00a0improvement","volume":"69","author":"Bhatt","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022031301250748900_B25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jchf.2015.09.002","article-title":"Heart rate or beta-blocker dose? Association with outcomes in ambulatory\u00a0heart failure patients with\u00a0systolic dysfunction: results from the HF-ACTION Trial","volume":"4","author":"Fiuzat","year":"2016","journal-title":"JACC Heart Fail"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc17-1406","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/41\/1\/136\/554370\/dc171406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/41\/1\/136\/554370\/dc171406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T05:14:49Z","timestamp":1647148489000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/41\/1\/136\/36671\/Mortality-Reduction-Associated-With-Adrenoceptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,10,5]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc17-1406","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,5]]}}}